The analysis supports the integration of sodium-glucose cotransporter 2 (SGLT2) inhibitors into treatment paradigms for ...

The most serious outcome of kidney disease develops when kidneys are only working at 15% capacity or lower. Anemia occurs when the body has a lower number of healthy red blood cells or hemoglobin ...

Converting from the long-acting ESA methoxy polyethylene glycol-epoetin-ß (MPG-EPO) to thrice weekly vadadustat is feasible for the hemodialysis population.

Hemoglobin requires iron to bring ... reduce and prevent anemia in people with chronic kidney disease. Medicines: EPO itself can be given as a shot. Shots of erythropoiesis-stimulating agents ...